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1. Introduction 
Cystic Fibrosis is a lethal autosomal recessive lung disorder resulting from a mutation in the 
transmembrane conductance regulator (CFTR) protein. The CFTR is a chloride channel 
encoded by a single gene on chromosome 7.  More than 1200 mutations have been identified 
that result in defective or absent CFTR protein [1]. The most common mutation is ΔF508 
(deletion of phenylalanine 508).  This deletion leads to a non-functional, misfolded protein 
that is subsequently degraded [2]. While multiple organ systems are affected, CF is most 
often characterized by thickened mucus secretions and an inability to clear the lungs [1, 3-4].   
In recent decades, improvements in life expectancy were achieved by new methods of 
antibiotic delivery as well as addition of new treatments to thin lung fluids.  An example is 
the use of DNase to clear the buildup of extracellular DNA that occurs in the CF lung.  This 
also relieves some of the exaggerated inflammatory response that is a characteristic of the 
CF lung [5].   
Over their life time, CF patients experience multiple infections by various pneumonia-
causing bacteria [6].  With more patients surviving to adulthood, chronic infections with 
Pseudomonas aeruginosa are coming to the forefront as a leading cause of death [7].  Problems 
presented by infected CF lung are multi-dimensional; the electrolyte balance and pH of the 
fluids are abnormal. The mucus is thick and of an alternative composition compared to 
normal lung and may contribute to colonization with Pseudomonas aeruginosa [2, 3, 5]. As 
such, research is multi-pronged and includes gene therapy to correct the defective protein, 
amelioration of inflammatory response and thinning of alveolar surface fluids [8, 9]. 
Significantly, Pseudomonas bacteria colonize the CF lung far easier than normal lung.  
Normal lung tissue has several naturally occurring defenses that work in concert with 
commonly prescribed antibiotics for recovery from lung infections [4, 10]. The CF patient 
appears to lack these natural defenses [1, 7].  
Pseudomonas aeruginosa biofilms are difficult to treat due to multi-drug resistance. Many 
aspects of biofilms from physical structure to genetics and protein expression are under heavy 
investigation to elucidate the mechanisms by which biofilms develop antibiotic resistance. 
Within the biofilm matrix, bacteria are well protected from hostile environmental elements 
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and host defenses. Cells in different areas of the biofilm take on various patterns of gene 
expression, as such; biofilms are described as a community or as functioning similar to a multi-
cellular organism [3].  Biofilms develop slowly, destroy surrounding tissue and evade even 
healthy immune systems. Standard dose antibiotic therapy can reduce biofilm as well as 
planktonic cells shed from the biofilm, but rarely eradicate the entire biofilm.  This allows a 
cycle of subsequent regrowth and new shedding of planktonic cells which possess altered 
antibiotic resistance [11].  Some theories describe the heavy matrix, flow channels and oxygen 
gradients within the biofilm structure as contributing to problems with penetration of 
antibiotics into the biofilm.  Others describe a counteraction of host defenses or alterations in 
gene and protein expression not only within the biofilm, but also in the CF host [11-13].   In 
this proposal we will discuss a novel experimental approach to study the pharmacodynamics 
of antibiotics used to treat Pseudomonas aeruginosa biofilms in CF lung versus normal lung.  
Pseudomonas aeruginosa is an important human pathogen that can cause a wide range of 
infectious diseases that are associated with high morbidity and mortality rates [14]. Exposed 
tissue surfaces lined with epithelia are the most common targets of that pathogen e.g. 
epithelial surface of the eye and airways. 
Adhesion of Pseudomonas aeruginosa to the airway cellular receptors is the initial event to 
establish respiratory colonization and infection [12, 15-16]. Interestingly, the affinity of 
Pseudomonas aeruginosa to bind to the inflamed or injured epithelial cells (CF or mechanically 
ventilated patients) is significantly higher than that to bind normal cell surfaces; thus 
preventing bacterial adherence may minimize lung pathology for high-risk patients [16].   
The exploit of natural compounds, especially carbohydrates, to prevent infection has been 
considered in lung infectivity studies; since bacteria associated with pneumonia is known to 
bind the carbohydrate receptors on the pulmonary epithelium [12]. Dextran, a polymer of α 
(11,16) linked D- glucose (branched at the 3 position), is a widely available polysaccharide 
that has been used in the in vitro and in vivo infection models to block the adherence of 
Pseudomonas aeruginosa, Hemophilus influenza and Staphylococcus aureus [12, 15]. Berries of 
Vaccinium family (include cranberry) and their extracts that contain a saccharide effective in 
preventing the attachment of Escherichia coli to the uroepithelial receptors are well-known 
examples as well [12]. 
Recent studies suggested that many pathogenic organisms have the ability to invade and 
reside in the host cells during the early stage of infection. The discovery of antibiotic-
resistant intracellular Heamophilus influenzae in the lung of individuals with Chronic 
Obstructive Pulmonary Disease (COPD) implicates intracellular bacteria as an important 
reservoir for the persistent infection [17]. Pseudomonas aeruginosa can also survive for up to 
24 hours inside the lung epithelium without inducing cytotoxicity and is known to develop 
resistance to the treatments afterwards [17]. Accordingly, it is equally substantial to combat 
bacterial adhesion and invasion as a preventive step of the infection as well as the 
development of bacterial resistance. 
It has been reported that some inexpensive natural extracts (e.g. Berries of Vaccinium family 
and dextran) have shown promising anti-adhesion properties with some micro-organisms 
(e.g. Escherichia coli) in the urinary tract infections, therefore, they might worth testing as 
topical therapeutics for prevention of Pseudomonas aeruginosa adhesion and invasion to lung 
epithelial cells [18-19].   
In this study, the efficacy of some natural extracts with potential anti-adhesion properties 
and their combinations with ciprofloxacin was evaluated as blocking agents for the adhesion 
and the invasion of Pseudomonas aeruginosa PAO1 to A549 lung epithelial cells.  
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2. Building CF infection model 
Ciprofloxacin and gentamicin sulfate were purchased from Sigma/Aldrich (St. Louis, MO, 
USA) and their stock solutions were prepared in 0.1N HCl (32 mg/ml) and water (32 
mg/ml), respectively, and stored at -80oC. Before use; the antibiotic dilutions were made in 
F12-K cell culture medium (Cellgro, Mediatech, Inc, Manassas, VA, USA).  Other Cell 
culture reagents were also obtained from Cellgro, Mediatech Inc. (Manassas, VA, USA).  
Dextran of molecular weight (MW) 40,000 was provided by Dr. John Brekke (University of 
Minnesota Duluth, MN, USA). Bacterial culture reagents were obtained from Difco 
Laboratories (Detroit, MI, USA). 
The commercially available Vaccinium macrocarpon (cranberries) and Glycine max (soybean) 
were blended and extracted with distilled water (1:1 and 1:3.5, respectively) at room 
temperature.  
Both crude mixtures were left to decant overnight at 4oC. Their supernatants were then 
subjected to two steps centrifugation at 4750 rpm for 20 min followed by 12,000 rpm for 10 
min. The resultant supernatants were membrane filtered (0.22 µm, Millipore Corp. Billerica, 
MA). The sterile extracts were then stored at -80oC in 1ml aliquots till they were used in the 
adhesion or invasion assays.  
The concentrations of the solid contents of such extracts were determined by evaporating 
the water content at 40oC and weighing the solid residues until constant weights were 
achieved. 
Pseudomonas aeruginosa strain PAO1 was purchased from American Type Culture Collection 
(ATCC, Rockville, MD). P. aeruginosa PAO1 was grown until achieving the exponential 
growth phase over 16 hours at 37oC in Cation Adjusted Muller Hinton Broth (CAMHB) 
(Sigma-Aldrich, St. Louis. MO) from which 0.5 McFarland (1.5 × 108 CFU/ml) was prepared 
in F12-K tissue culture medium to initiate adhesion or invasion assays.  
A549 lung epithelial cell line was obtained from American Type Culture Collection (ATCC, 
Rockville, MD). The cells were passed in 75 cm2 flasks (BD Falcon, San Jose, CA), and then 
1.5 x 105 cells were counted using the Hemocytometer and seeded into 12 well tissue culture 
plates (Becton Dickinson, NJ, USA). The cells were incubated in F12-K medium 
supplemented with 10% (vol/vol) Fetal Bovine Serum (FBS) at 37oC in the presence of 5% 
CO2 to achieve confluence over 48 hours.  
Minimum Inhibitory Concentration (MIC) and Minimum Cytotoxic Concentration (MCC) 
were two factors controlled the choice of the extract or ciprofloxacin concentrations selected 
in the adhesion and invasion assays.  In order to prevent adhesion or invasion, the bacterial 
cells need to be alive but incapable of clinging to or intruding into the lung epithelial cells; 
therefore, sub-MIC had to be determined prior to the assays.  On the other hand, the lung 
cells integrity was kept intact via using sub-MCC of the different tested agents. MICs were 
determined according to the Clinical and Laboratory Standards Institute (CLSI, M7-A7 and 
M100-S16, Criteria for Pseudomonas aeruginosa). Cytotoxicity of the tested agents against the 
A549 lung epithelial cell line was determined using crystal violet nuclei staining method as 
described by Gillies, et al. (1986) [10] with minor modifications. Briefly, confluent monolayer 
of A549 lung epithelial cell was incubated for 2 hrs with 200 µl of two-fold serial dilutions of 
different tested agents prepared in F12-K Medium, and then the cells were washed twice 
with phosphate-buffered saline (PBS). After rinsing, the cells were fixed with 1% (vol/vol) 
gluteraldehyde (Sigma/Aldrich, St. Louis, MO) and stained with 0.1% crystal violet (Fisher 
Scientific, Pittsburgh, PA) for 15 min. The dye was removed through multiples sterile water 
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rinsing and the absorbed crystal violet was then dissolved with 0.5% (vol/vol) Triton X-100 
(Sigma/Aldrich, St. Louis, MO).  
Absorbance was measured at λ590 nm using SynergyTM2 Microplate Reader (BioTech 
Instruments, Inc. Vermont, USA). Absorbance data were analyzed using Excel spread sheet 
and sub-MCCs were determined for different agents.     
For SEM analysis, A549 lung epithelial cells were challenged with PAO1 cells for 1 hour, 
washed 3 times with F12-K medium and subsequently fixed with 5% (vol/vol) 
gluteraldehyde over 24 hours. The cells were then flushed with sterile deionized water to 
remove salts and dried before scanning with JSM-6490LV SEM (Peabody, Massachusetts) 
equipped with a tungsten filament, an accelerating voltages of 15-20 kV and a chamber 
pressure of 60-70 Pa according to the method described by Carterson et al with minor 
modifications [11]. All infectivity studies were carried out in a sterile class II biological 
safety cabinet (Sterilgard III Advance, Baker Company, Sanford, Maine, USA) according to 
the method described Plotkowski, et al [12] with some modifications. Initially, the confluent 
monolayer of A549 lung epithelial cells  was incubated with 500µl fresh F12-K cell culture 
medium (control wells), 500µl of the natural extract or combination solutions (natural 
extract and ciprofloxacin) in F12-K medium at 37oC for 15 min followed by mixing with 
500µl of 0.5  McFarland (1.5 × 108 CFU/ml) suspension of P. aeruginosa PAO1 prepared in 
F12-K medium for one minute to achieve homogenous bacterial distribution in MultiwellTM 
12-well tissue culture plate (Becton Dickinson, NJ, USA). Ciprofloxacin (0.0625 µg/ml), 
dextran (50.0 mg/ml), and the aqueous extracts of soybean (42.8 mg/ml), and cranberry 
(25.4 mg/ml) as well as the combinations of the three later agents with ciprofloxacin were 
applied as potential anti-adhesion agents in the aforementioned assay. The mixture was 
incubated at 37oC for 1 hour to establish bacterial adhesion. Each plate had a control well 
and all experiments were carried out in triplicates. 
At the end of the incubation time, cells were gently washed thrice with FBS free F12-K 
medium to eliminate the non-adhered bacterial cells of P. aeruginosa PAO1 and then lysis of 
the mammalian cells was carried out with 1ml of 1% (vol/vol) tween-20 (Astoria-Pacific, 
Clackamas, Oregon, USA) at 37oC for 30 min.  
After lysis, ten-fold serial dilutions for the P. aeruginosa PAO1 suspension in each well 
followed by plating onto Cation Adjusted Muller Hinton II (CAMHII) agar were carried out. 
All CAMHII agar plates were incubated at 37oC for 18 hours for determining CFU/ml 
through viable cell counting for different treatments as well as for the untreated control. 
Percentage adhesion for each treatment relative to the untreated control was calculated and 
the averages of triplicate experiments were expressed graphically + standard deviations 
(S.D). Data analysis was carried out using Graphpad prism 5 (GraphPad Software Inc. La 
Jolla, CA ) that utilized One Way Analysis of Variance (ANOVA) followed by Dunnett 
Multiple Comparison test to determine the significant treatment differences as compared to 
the untreated control.           
Parallel experiments were carried out as described under adhesion assay except for an extra 
step performed to assess P. aeruginosa PAO1 invasion into A549 lung epithelial cells. After 
15 min incubation with 500 µL of the drug or the combination solutions in F12-K medium at 
37oC, bacterial suspension (500 µL of 0.5 McFarland) was added and mixed with the 
aforementioned solutions for 1min in MultiwellTM 12-well tissue culture plates. The plates 
were incubated at 37oC for 2 hours to allow for invasion. Gentamicin exclusion method as 
described by Fleiszig et al [13] was then used to kill the adherent bacterial cells. This step 
involved washing of the adherent cells with FBS free F12-K medium followed by incubation 
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of the infected cells with fresh F12-K medium containing 300µg/ml gentamicin for 1 hour at 
37oC. After incubation, the dead bacteria were washed thrice with FBS free F12-K medium 
and the lung epithelial cells A549 were lysed with 1% (vol/vol) Tween-20 solution to 
determine the count of internalized P. aeruginosa PAO1 cells. The resultant cell suspensions 
were tenfold serially diluted, plated onto CAMHII agar plates, and incubated as previously 
described under adhesion assay. 
Percentage invasion for each treatment relative to the control was calculated and the 
averages of triplicate experiments were expressed graphically + standard deviations (S.D). 
Data analyses were carried out using Graphpad Prism 5 (GraphPad Software Inc. La Jolla, 
CA) that utilized the one way ANOVA followed by Dunnett Multiple Comparison 
adjustment to determine the significance of treatment differences on the invasion of P. 
aeruginosa PAO1 as compared to the control.   
Adhesion of P. aeruginosa PAO1 to lung epithelial cells A549 was visualized using Scanning 
Electron Microscopy (SEM). Imaging revealed that P. aeruginosa PAO1 could adhere to the 
lung epithelial cells without disrupting the lung cells morphology (Figure 1).  
 
 
Fig. 1. Scanning Electron Micrograph illustrating the adherence of  Pseudomonas aeruginosa 
PAO1 to A549 lung epithelial cells. 
The soluble solid ingredients for the applied extracts were determined as described under 
Materials and Methods and their concentrations were 50.9 mg/ml and 85.7 mg/ml for the 
aqueous extracts of cranberry, and soybean respectively. Dextran was applied at a 
concentration level of 50.0 mg/ml. 
MIC of ciprofloxacin and natural extracts against P. aeruginosa PAO1 and MCC of the same 
agents on A549 lung epithelial cells were determined according to CLSI criteria and the 
method described by Gillies et al. [10], respectively. The results showed that all the tested 
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natural extracts had relatively high concentrations of MICs against P. aeruginosa PAO1 and 
of MCC on A549 lung epithelial cells (Table 1). These results may indicate that these agents 
are relatively non-toxic to the A549 lung epithelial cells as well as they cannot inhibit the 
growth of P. aeruginosa PAO1 at the tested concentrations.  
 
Treatment MICa (µg/ml) MCCb (µg/ml) 
Ciprofloxacin 0.125 > 64 
Dextran >10000 >10000 
Cranberry Extract >5090 >5090 
Soybean Extract >8570 >8570 
aMinimum Inhibitory Concentration 
bMinimum Cytotoxic Concentration 
Table 1. MIC and MCC (µg/ml) values for ciprofloxacin and different natural extracts 
against P. aeruginosa PAO1 and A549 lung epithelial cells, respectively. 
Based on the data shown in table (1), sub-MIC and sub-MCC concentrations of both 
ciprofloxacin and the natural extracts were selected in the adhesion and invasion assays to 
evaluate their effects, as single agents or in combination with ciprofloxacin, on P. aeruginosa 
PAO1 adhesion and invasion without interfering with the viability of the bacterial or 
mammalian cells. Accordingly, ciprofloxacin (0.0625 µg/ml), dextran (50.0 mg/ml), 
cranberry extract (25.5 mg/ml), and soybean extract (42.8 mg/ml) were selected at their 
subMIC/subMCC for testing the effects of the single treatments on P. aeruginosa PAO1 
adhesion and invasion to the lung epithelial cells. In combination treatments, the effect of 
ciprofloxacin (0.0625 µg/ml) on the adhesion and invasion of P. aeruginosa PAO1 was 
assessed with halves of the aforementioned concentrations of the tested single agents. 
2.1 Effect of natural extracts and their combinations with ciprofloxacin on the 
adhesion of P. aeruginosa PAO1 to A549 lung epithelial cells  
Adhesion of the P. aeruginosa PAO1 to the lung epithelial cells was assessed through viable 
cell counting of the bound bacteria to the cell surface from each independent triplicate 
experiment and the untreated controls. Adhesion of P. aeruginosa PAO1 to A549 lung 
epithelial cells in the presence of different natural extracts, as single agents and in 
combination with ciprofloxacin, was expressed as the percentage of adhered bacterial cells 
to the epithelial cell surface and normalized to that of the untreated controls. In that regard, 
ciprofloxacin (0.0625 µg/ml), dextran (50.0 mg/ml), cranberry extract (25.5 mg/ml), 
soybean extract (42.8 mg/ml) could reduce P. aeruginosa PAO1 adhesion by 26.3%, 16.4%, 
54.5%, and 45%, respectively compared to the untreated control. On the other hand, 
ciprofloxacin combination with dextran (25.0 mg/ml), cranberry extract (12.7 mg/ml), 
soybean extract (21.4 mg/ml) could reduce P. aeruginosa PAO1 adhesion by 87.5%, 100%, 
and 72%, respectively as compared to that of the control (Figure 2). Interestingly, 
combination of ciprofloxacin (0.0625 µg/ml) with cranberry extract (12.7 mg/ml) could 
completely inhibit the adhesion (0.0%) of P. aeruginosa PAO1 to A549 lung epithelial cells. 
Although dextran was relatively the least effective single anti-adhesion treatment 
(83.6%±12.1%), it achieved a significant higher effect upon combination with ciprofloxacin 
(12.5%±4.2%). 
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Soybean extract was an effective anti-adhesion agent (55.0%±6.4%) compared to 
ciprofloxacin (73.7%±2.08%) and their combination could synergistically (28.03%±0.65%) 
and significantly (P<0.0001) reduce the ability of P. aeruginosa PAO1 to adhere to the A549 
lung epithelial cells (Figure 2).  
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Fig. 2. The effect of different natural extracts alone and in combination with ciprofloxacin on 
the adhesion of P. aeruginosa PAO1 to A549 lung epithelial cells as compared to the 
untreated control.  
2.2 Effect of natural extracts and their combinations with ciprofloxacin on the 
invasion of P. aeruginosa PAO1 to A549 lung epithelial cells 
The ability of the adhered bacterial cells to internalize into the lung epithelial cells in the 
presence of different natural extracts, as single agents or in combination with ciprofloxacin, 
was assessed through calculation of percentage invasion of P. aeruginosa PAO1 from three 
independent experiments relative to the untreated controls. The results of gentamicin 
exclusion assay are believed to reflect the count of bacteria that has invaded cells [4, 13] with 
different treatments. Expectedly, both single cranberry and combination with ciprofloxacin 
were able to completely abrogate the invasion of P. aeruginosa PAO1 to the lung cells (0.0%). 
Although 45.5%±6.7% of the initial bacterial inoculum was able to bind to the epithelial cells 
after treatment in the presence of cranberry extract, none of this adhered population was 
able to penetrate the lung epithelial cells. Following  the synergistic effect of cranberry 
extract, the combination of ciprofloxacin with both of soybean (17.6%±7.12%) and dextran 
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(11.8%±2.1%) achieved comparable and significant (P<0.0001) anti-invasion effects 
compared to the control. Similar to the results for the adhesion assay, dextran and soybean 
were more effective in combination with ciprofloxacin in preventing invasion rather than 
the single agents (75.5%±2.1%) and (17.6%±11.8%) as shown in figure (3).  
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Fig. 3. The effect of different natural extracts alone and in combination with ciprofloxacin on 
the invasion of P. aeruginosa PAO1 to A549 lung epithelial cells as compared to the untreated 
control. 
3. Discussion 
Pseudomonas aeruginosa is a major cause for mortality seen in CF patients [6]. Adhesion and 
subsequent invasion of that organism to the lung epithelial cells are considered as the initial 
and substantial steps in the lung infection [5, 14-16].  Once the colonization of the organism 
is established, it is rarely eradicated. Several strategies have been developed to prevent P. 
aeruginosa infection in CF patients through different antibiotics and immunizations, but 
were not successful [8, 17-19]; therefore, development of other prophylactic measures as 
anti-adhesion and anti-invasion approaches is required.  Ciprofloxacin, a fluoroquinolone, is 
considered as an antibiotic of choice for the treatment of the lung infections with 
Pseudomonas aeruginosa [7]. The current study aimed at introducing a new strategy to 
prevent Pseudomonas aeruginosa adhesion and invasion to the lung epithelial cells using 
different combinations of ciprofloxacin and aqueous extracts from widely available natural 
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products such as cranberry, and soybean. Dextran, which has been tested before in many 
occasions and found to be an effective anti-adhesion agent [2, 8, 11], was tested on that 
epithelial cell infection model as well to assess its anti-adhesion and anti-invasion activities 
compared to the other natural products, alone and in combination with ciprofloxacin. 
The virulence factors of different Pseudomonas aeruginosa strains were attributed either to 
their direct host cell cytotoxicity or ability to adhere, invade, and survive within the 
epithelial cells. P. aeruginosa PAO1 virulence is categorized under the second types of 
isolates and invasion of that strain was suggested to contribute to biofilm formation and 
establishment of chronic lung infections [7]. Interestingly, the binding of Pseudomonas 
aeruginosa to the uninjured epithelial surfaces was found to be minimal. However, the 
binding ability of the organism increases dramatically in presence of epithelial surface 
inflammation or injury (such as in CF patients) [6, 20].  Scanning electron microscopy 
imaging revealed establishment of P. aeruginosa PAO1 binding to lung epithelial cells as the 
first step of Pseudomonas aeruginosa infection. Such binding did not affect the cells integrity 
or morphology (Figure1). Similarly, Fleiszig et al. [13] noted that integrity of the infected 
cells remains unaffected since the strain P. aeruginosa PAO1 does not use cytotoxicity as a 
virulence mechanism against the lung epithelial cells.   
In order to exclude the inhibitory effect of ciprofloxacin and the applied natural extracts on 
P. aeruginosa PAO1 and A549 lung epithelial cells, the MICs of ciprofloxacin and the natural 
extracts against P. aeruginosa PAO1 and the MCCs of the same agents were determined to 
aid selection of the concentrations of different agents that will be tested on the adhesion and 
invasion models. 
Unsurprisingly, the MICs and MCCs values could not be reached within the tested 
concentration levels for the different natural extracts, which were relatively high compared 
to ciprofloxacin, indicating that they are relatively non-toxic to the A549 lung epithelial cells 
as well as to P. aeruginosa PAO1.  It has been reported that extracts of the natural sources are 
considered as endless reservoirs of safe and relatively inexpensive bioactive agents [9]. 
Dextran is a widely available polysaccharide that has been used in clinical settings as 
plasma expander [2]. It was previously tested as a carbohydrate treatment that blocks the 
epithelial glycoconjugates and impedes the bacterial legends from binding to pulmonary 
epithelial cell receptors [2].  Aerosolized dextran has been examined in a mouse infection 
model to prevent pneumonia caused by Pseudomonas aeruginosa and it could significantly 
reduce the development of pneumonia in the treated group relative to the untreated control 
animals,   being an immuno-stimulant and a sputum rheology enhancer [2]. 
The combination treatment of dextran with ciprofloxacin disabled the internalization 
abilities of 85% of the bacterial population that adhered in the control experiments. 
Application of dextran resulted in an average of 14% reduction in both adhesion and 
invasion of P. aeruginosa PAO1 to the lung epithelia. This reduction is slightly less than that 
was found by Bryan et al. [2] who reported 35% reduction on P. aeruginosa PAO1 adhesion to 
nasal polyp primary culture cells when pretreated with dextran. Factors such as difference 
in the cell culture type or the experimental conditions may provide an explanation for the 
disparity in the activities. The same authors proposed that the likely mechanism through 
which dextran blocks bacterial adhesion was through the non-specific interaction with the 
epithelial cells; since pre-incubation of P. aeruginosa PAO1 with dextran before performing 
the infection abolished its anti-adhesion properties [2]. Consequently, the inhibitory action 
of dextran might not only involve P. aeruginosa PAO1 adhesion, but also other potential 
pathogens especially those targeting respiratory epithelia.  
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To our knowledge, there were no previous studies that reported the utilization of soybean 
extract as a potential anti-adhesion or anti-invasion treatment. The present study, however, 
proposes that the aqueous extract of soybean (Glycine max) is an additional promising 
treatment against adhesion and invasion of P. aeruginosa PAO1 to the lung epithelial cells. 
Compared to the control treatment, 28% and 17% of the applied bacterial inoculum were 
able to adhere and invade the lung epithelial cells, respectively, upon application of soybean 
extract combination with ciprofloxacin. These results suggest that on average half of the 
bacterial population that were able to adhere after treatment with soybean extract were  not 
capable to invade the lung epithelial cells  
Aqueous extract of cranberry (Vaccinium macrocarpon) was by far the most effective anti-
adhesion and anti-invasion treatment when used in combination with ciprofloxacin. 
Cranberry belongs to Vaccinum family that has a wide spectrum of in vitro antimicrobial 
activity [21]. Many reports have demonstrated that proanthocyanidines and saccharides of 
cranberry were able to inhibit adhesion and invasion of some pathogenic microbes in vitro, 
and that cranberry juice clinically prevents urinary tract infection in women by inhibiting 
Escherichia coli adhesion to uroepithelial glycolipid receptors [3, 9]. The activity of the 
cranberry extract extended to provide protection against resistant strains of Escherichia coli 
by a mechanism that is unlikely to increase the selective pressure associated with antibiotics 
resistance [3]. Therefore, combining cranberry extract with ciprofloxacin sub-MIC may block 
the initial steps of infection, adhesion and invasion, as well as minimizing the development 
of bacterial resistance. 
The results of this study may indicate that cranberry extract could turn the adhered bacteria 
unable to invade the lung epithelial cells since 45% of P. aeruginosa PAO1 population that 
were able to adhere to the lung cells under treatment with cranberry were, simultaneously, 
incapable of  invading those cells and further molecular studies are required to elucidate 
this interesting point.  
In published randomized clinical trial, cranberry juice was found to only affect harmful 
bacteria leaving normal bacterial flora unaffected; an observation that could suggest the 
therapeutic benefits of cranberry without having major unexpected side effects [21]. 
Cranberry juice, capsules and powder were also found to reduce urinary tract infection 
recurrences as well as the salival counts of the bacteria causing dental carries [21-24].  
The significance of proposing the anti-adhesion treatments emanates from the fact that the 
earlier the establishment of airway infection is prevented the better the expected therapeutic 
outcome; since the persistence of intracellular bacteria causes sloughing of epithelial cells 
containing these bacteria and may contribute to spreading of the infection,  establishment of 
the biofilm, rendering the bacterial eradication by the antibiotics difficult and favoring  the 
bacterial  endurance in the host airway [7]. 
In light of these in vitro anti-adhesion and anti-invasion effects of the promising   natural 
extracts, further in vivo studies are required to explore their putative applications as an 
alternative strategy to combat the respiratory infections and the potential reduction of the 
antibiotic resistance rates.  
4. Abbreviations 
CF: Cystic Fibrosis 
COPD: Chronic Obstructive Pulmonary Disease 
CAMHB: Cation Adjusted Muller Hinton Broth  
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MIC: Minimum Inhibitory Concentration  
MCC: Minimum Cytotoxic Concentration  
CLSI: Clinical and Laboratory Standards Institute  
SEM: Scanning Electron Microscopy  
ANOVA: Analysis of Variance  
5. References 
[1] Gambardella S, Biancolella M, D’Apice MR et al. Gene expression profile in CFTR 
mutated bronchial cell lines.Clin Exp Med 2006; 6:157-165. 
[2] Soferman R. Immunopathophysiologic mechanisms of cystic fibrosis lung disease. IMAJ 
2006; 8:44-48. 
[3] Singh AP, Chauhan SC, Andrianifahanana M, et al. MUC4 expression is regulated by 
cystic fibrosis transmembrane conductance regulator in pancreatic adenocarcinoma 
cells via transcriptional and post-translational mechanisms. Oncogene 2007; 26:30-
41. 
[4] Moskwa P, Lorentzen D, Excoffon KJ, et al. A novel host defense system of airway is 
defective in cystic fibrosis.Am J Respir Crit Care Med 2007; 175:174-183. 
[5] Blau H. Cystic fibrosis lung disease: interplay of a microbial microcosm and extremes of 
inflammation IMAJ 2006; 8:58-59. 
[6] Bilton D, Henig N, Morrissey B and Golfried Ml. Addition of inhaled tobramycin to 
ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult 
bronchiectasis. Chest 2006; 130:1503-1510.  
[7] Smyth A. Update on treatment of pulmonary exacerbations in cystic fibrosis Curr Opin 
Pulm Med 2006; 12:440-444. 
[8] McLachlan G, Baker A, Tennant P, et al. Optimizing aerosol gene delivery and 
expression in the ovine lung .Molecular Therapy 2007; 15:348-354. 
[9] Fischer AC, Smith CL, Cebotaru L, Zhang X, et al. et al. Expression of a truncated cystic 
fibrosis transmembrane conductance regulator with an AAV5-pseudotyped vector 
in primates. Molecular Therapy, 15(4):756-63. 
[10] Delgado MA, Poschet JF, Deretic Vl. Nonclassical pathway of Pseudomonas aeruginosa 
DNA-induced interleukin-8 secretion in cystic fibrosis airway epithelial 
cells.Infection and Immunity 2006; 74(5):2975-2984. 
[11] Bavington C, and Page C. Stopping bacterial adhesion: a novel approach to treating 
infections. Respiration 2005;72: 335-344.  
[12] Bryan R, Feldman M, Jawetz SC et al. The effects of aerosolized dextran in a mouse 
model of Pseudomonas aeruginosa pulmonary infection. J Infect Dis 1999;179: 1449-
1458.  
[13] Howell AB, Vorsa N, Der Marderosian A, Foo LY. Inhibition of the adherence of P-
fimbriated Escherichia coli to uroepithelial-cell surfaces by proanthocyanidin 
extracts from cranberries. N Engl J Med 1998;339:1085-1086.  
[14] Angus AA, Lee AA, Augustin DK  et al. Pseudomonas aeruginosa induces membrane 
blebs in epithelial cells, which are utilized as a niche for intracellular replication 
and motility. Infect Immun 2008;76:1992-2001.  
[15] Imundo L, Barasch J, Prince A, Al-Awqati Q. Cystic fibrosis epithelial cells have a 
receptor for pathogenic bacteria on their apical surface. Proc Natl Acad Sci U.S.A 
1995;92:3019-3023.  
www.intechopen.com
 
Lung Diseases – Selected State of the Art Reviews 
 
440 
[16] Swanson B, Savel R, Szoka F, Sawa T,Wiener-Kronish J. Development of a high 
throughput Pseudomonas aeruginosa epithelial cell adhesion assay. J Microbiol 
Methods 2003;52:361-366.  
[17] Garcia-Medina R, Dunne WM, Singh PK, Brody SL. Pseudomonas aeruginosa acquires 
biofilm-like properties within airway epithelial cells. Infect Immun 2005;73:8298-
8305.  
[18] Barghouthi S, Guerdoud LM, Speert DP. Inhibition by dextran of Pseudomonas aeruginosa 
adherence to epithelial cells. Am J Respir Crit Care Med 1996;154:1788-1793.  
[19] Howell AB, and Foxman B. Cranberry juice and adhesion of antibiotic-resistant 
uropathogens. JAMA 2002;287:3082-3083.  
[20] Gillies RJ, Didier N, Denton M. Determination of cell number in monolayer cultures. 
Anal Biochem 1986;159:109-113.  
[21] Carterson AJ, Honer Bentrup K, Ott CM et al. A549 lung epithelial cells grown as three-
dimensional aggregates: alternative tissue culture model for Pseudomonas aeruginosa 
pathogenesis. Infect Immun 2005;73:1129-1140.  
[22] Plotkowski MC, Saliba AM, Pereira SH, Cervante MP, Bajolet-Laudinat O. Pseudomonas 
aeruginosa selective adherence to and entry into human endothelial cells. Infect 
Immun 1994;62:5456-5463.  
[23] Fleiszig SM, Zaidi TS, Preston MJ, Grout M, Evans DJ et al. Relationship between 
cytotoxicity and corneal epithelial cell invasion by clinical isolates of Pseudomonas 
aeruginosa. Infect Immun 1996;64:2288-2294.  
[24] Beachey EH. Bacterial adherence: adhesin-receptor interactions mediating the 
attachment of bacteria to mucosal surface. J Infect Dis 1981;143:325-345.  
[25] Kallenius G, Mollby R, Svenson SB, Winberg J. Microbial adhesion and the urinary 
tract. Lancet 1981;318(8251):866.  
[26] Boren T, Falk P, Roth KA, Larson G, Normark S. Attachment of Helicobacter pylori to 
human gastric epithelium mediated by blood group antigens. Science 
1993;262:1892-1895.  
[27] Speert DP. Prevention of severe lower respiratory infections in patients with cystic 
fibrosis. Semin Respir Infect 1989;4:266-271.  
[28] Pennington JE, Reynolds HY, Wood RE, Robinson RA, Levine AS. Use of a Pseudomonas 
Aeruginosa vaccine in pateints with acute leukemia and cystic fibrosis. Am J Med 
1975;58:629-636.  
[29] Wood RE, Pennington JE, Reynolds HY. Intranasal administration of a Pseudomonas 
lipopolysaccharide vaccine in cystic fibrosis patients. Pediatr Infect Dis 1983;2:367-369.  
[30] Bentzmann S, Roger P, Puchelle E. Pseudomonas aeruginosa adherence to remodelling 
respiratory epithelium. Eur Respir J 1996;9:2145-2150.  
[31] Kontiokari T, Salo J, Eerola E, Uhari M. Cranberry juice and bacterial colonization in 
children: a placebo-controlled randomized trial. Clin Nutr 2005;24:1065-1072.  
[32] Weiss EI, Kozlovsky A, Steinberg D, Lev-Dor R, Bar Ness GR. et al. A high molecular 
mass cranberry constituent reduces mutans streptococci level in saliva and inhibits 
in vitro adhesion to hydroxyapatite. FEMS Microbiol Lett 2004;232:89-92.  
[33] Avorn J, Monane M, Gurwitz JH, Glynn RJ, Choodnovskiy I. et al. Reduction of 
bacteriuria and pyuria after ingestion of cranberry juice. JAMA 1994;271:751-754.  
[34] Stothers L. A randomized trial to evaluate effectiveness and cost effectiveness of 
naturopathic cranberry products as prophylaxis against urinary tract infection in 
women. Can J Urol 2002;9:1558-1562.  
 
www.intechopen.com
Lung Diseases - Selected State of the Art Reviews
Edited by Dr. Elvisegran Malcolm Irusen
ISBN 978-953-51-0180-2
Hard cover, 690 pages
Publisher InTech
Published online 02, March, 2012
Published in print edition March, 2012
InTech Europe
University Campus STeP Ri Slavka Krautzeka 83/A 51000 Rijeka, Croatia Phone: +385 (51) 770 447 Fax: +385 (51) 686 166www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 Fax: +86-21-62489821
The developments in molecular medicine are transforming respiratory medicine. Leading clinicians andscientists in the world have brought their knowledge and experience in their contributions to this book.Clinicians and researchers will learn about the most recent advances in a variety of lung diseases that willbetter enable them to understand respiratory disorders. This treatise presents state of the art essays onairways disease, neoplastic diseases, and pediatric respiratory conditions. Additionally, aspects of immuneregulation, respiratory infections, acute lung injury/ARDS, pulmonary edema, functional evaluation inrespiratory disorders, and a variety of other conditions are also discussed. The book will be invaluable toclinicians who keep up with the current concepts, improve their diagnostic skills, and understand potential newtherapeutic applications in lung diseases, while scientists can contemplate a plethora of new research avenuesfor exploration.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Ayman M. Noreddin, Ghada Sawy, Walid Elkhatib, Ehab Noreddin and Atef Shibl (2012). Inhibition of Adhesionand Invasion of Pseudomonas aeruginosa to Lung Epithelial Cells: A Model of Cystic Fibrosis Infection, LungDiseases - Selected State of the Art Reviews, Dr. Elvisegran Malcolm Irusen (Ed.), ISBN: 978-953-51-0180-2,InTech, Available from: http://www.intechopen.com/books/lung-diseases-selected-state-of-the-art-reviews/inhibition-of-adhesion-and-invasion-of-pseudomonas-aeruginosa-to-lung-epithelial-cells-a-model-of-cy
